Condition

Graft Versus Host Disease (cGvHD) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Expanded regulatory T cells plus low-dose IL-2 for steroid-refractory chronic GVHD

  This trial tests whether a single dose of expanded regulatory T cells given with daily low-dose IL-2 can help children and adults with chronic GVHD that did not improve with steroids.

  Recruiting Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts · NCT06991361

• Evaluation of patients with immune function abnormalities

  This study is testing how immune problems affect people with conditions like XSCID and CGD to help find better treatments and understand their health over time.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00128973

Related topics

Quick answers

How many Graft Versus Host Disease (cGvHD) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →